BioCentury
ARTICLE | Company News

FDA accepts Andrx's metformin XT NDA

February 20, 2003 8:00 AM UTC

The FDA accepted for filing ADRX's NDA for its extended release metformin tablets to control blood sugar in patients with Type II diabetes. The compound uses ADRX's Scot drug delivery technology. ...